$RGNX
Regenxbio Inc
- NASDAQ
- Health Technology
- Biotechnology
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
PRICE
$20.07 ▲4.579%
Last Close
VOLUME
331,002
DAY RANGE
19.19 - 20.3
52 WEEK
17.02 - 35.73
Join Discuss about RGNX with like-minded investors
@dros #droscrew
recentlyTop Earnings Wed 5/3 Aft: $ACEL $ACLS $ACR $ACT $ADPT $AEIS $ALB $ALKT $ALL $ALLO $AMED $AMK $AMOT $AMPY $AMWL $ANSS $APA $ARC $ARDX $ASPN $ATO $ATUS $AUR $AVNW $AVT $BBSI $BCOV $BHE $BKH $BNL $CCRN $CDAY $CENT $CENTA $CFLT $CHRD $CIVI $CLMB $CMPO $CODI $COKE (1/6) Top Earnings Wed 5/3 Aft: $CORT $CPE $CPK $CPS $CRD/A $CSGS $CSTL $CSV $CTSH $CTVA $CW $CXW $DEN $DHT $DLHC $DRS $ECOR $ECPG $ELA $EQC $EQH $EQIX $ERII $ES $ESTE $ETSY $EVH $EZPW $FARO $FATE $FBRT $FG $FLT $FNF $FORM $FPI $FROG $FSLY $GHL $GIL $GKOS $GL $GMRE $GNK (2/6) Top Earnings Wed 5/3 Aft: $GNW $GOOD $GRBK $GTBIF $HBB $HCC $HDSN $HOUS $HST $HUBS $INFA $INFN $INMB $INN $INSG $IOSP $IPI $IR $IVAC $JOBY $KLIC $KNTK $KTOS $KW $LESL $LMND $LODE $LUMO $MELI $MET $METC $MG $MGY $MKSI $MLR $MMS $MOR $MOS $MRAM $MRO $MTG $MX $MYGN (3/6) Top Earnings Wed 5/3 Aft: $NARI $NC $NE $NFG $NGVT $NSTG $NUS $NVEC $NVST $NWPX $NYMT $O $OLED $OM $OPAD $OPK $OUT $PAHC $PARR $PCOR $PDCE $PGRE $PKOH $PLMR $PSA $PSNL $QCOM $QDEL $QGEN $QNST $QRVO $RDN $REI $RELY $REZI $RGLD $RGNX $RGR $RHP $RM $RMNI $RMR $ROOT (4/6) Top Earnings Wed 5/3 Aft: $RPT $RSI $RUN $RVLV $RYN $SBOW $SBRA $SEDG $SGU $SIGI $SITM $SNEX $SP $SPNT $SPOK $SRC $SRI $SRTS $STAA $STR $SUM $SYNA $TIPT $TNDM $TPIC $TPL $TPVG $TRIP $TSVT $TTEC $TTMI $TWI $TXG (5/6) Top Earnings Wed 5/3 Aft: $UDMY $UFI $UGI $ULCC $UPWK $USDP $USIO $USPH $VAC $VAPO $VET $VMEO $VNDA $VSTO $VTOL $WEAV $WERN $WES $WMB $WTS $YELL $Z $ZG $ZIMV (6/6)
137 Replies 7 👍 15 🔥
@DarkPoolAlgo #Dark Pool Charts
recentlyMonday, October 11, 2021 U.S. stock futures are edging lower ahead of the Columbus Day holiday, with oil prices extending last week gains and moving to fresh 7-year highs ahead of key inflation data later this week and the upcoming earnings season, which starts Friday with the big banks ($JPM, $Citi). Over the weekend, Goldman Sachs cuts its 2021 economic growth forecast by 10 basis points, to 5.6%, while lowering its 2022 estimate by 40 basis point to 4% citing a “longer lasting virus drag on virus-sensitive consumer services” and the impact of an extended shortage in global semiconductors. The bond market is closed today in observance of the Columbus Day holiday after the 10-year yield closed at 1.612% on Friday, the highest level of the week. Oil prices extending gains, as WTI crude rises over $2.20 or 2.8% above $81.50. In Asian markets, The Nikkei Index rose 449 points (1.6%%) to 28,498, the Shanghai Index was little changed at 3,591, and the Hang Seng Index jumped nearly 2% or 487 points to settle at 25,325. In Europe, the German DAX is down about -50 points to 15,150, while the FTSE 100 is up about 0.25% at 7,110. Q quiet day expected ahead with no economic data and bond markets closed. Market Closing Prices Yesterday · The S&P 500 Index dropped -8.42 points, or 0.19%, to 4,391.34 · The Dow Jones Industrial Average fell -8.69 points, or 0.03%, to 34,746.25 The Nasdaq Composite slid -74.48 points, or 0.51%, to 14,579.54 · The Russell 2000 Index declined -17.00 points, or 0.76% to 2,233.09 Events Calendar for Today · No Major Economic Data Earnings Calendar: · Earnings Before the Open: AZZ, ENZ, FAST · Earnings After the Close: PNFP, SGH Other Key Events: · American Society of Retina Specialists Annual Scientific Meeting, in San Antonio, TX 10/8-10/12 World News · Goldman Sachs cuts its forecast for U.S economic growth over the weekend, citing a “longer lasting virus drag on virus-sensitive consumer services” and the impact of an extended shortage in global semiconductors. Goldman trimmed its 2021 growth forecast by 10 basis points, to 5.6%, while lowering its 2022 estimate by 40 basis point to 4%, adding that consumer spending is likely to be held back by pandemic uncertainty and a softer-than-expected fiscal response from the Biden administration. · Taiwan will keep bolstering its defenses to ensure nobody can force them to accept the path China has laid down that offers neither freedom nor democracy, President Tsai Ing-wen said on Sunday – Reuters Sector News Breakdown Consumer · Southwest Airlines ($LUV) cancelled 808 flights yesterday and has cancelled another 1,006 today, according to data from Flightaware.com. The company blamed the disruption on air traffic control issues and weather, although other major airlines are not delaying or cancelling flights at an elevated rate. There was speculation that some Southwest employees have called in sick in a form of protest over the mandatory vaccination rules in place, which have been unconfirmed · Hasbro ($HAS) said CEO Brian Goldner will take a medical leave of absence, effective immediately, slightly more than a year after disclosing that he was undergoing continued medical care following treatment for cancer in 2014. Energy, Industrials and Materials · Honeywell ($HON) raised its business outlook for jet deliveries on Sunday as travel restrictions ease as they now see 7,400 new business jet deliveries worth $238 bln over the next 10 years, up 1% from the same 10-year forecast a year ago. Business jet operators surveyed by Honeywell reported a sharp increase in their used jet purchase plans, 12% above last year’s report · Emerson Electric ($EMR) plans to merge two of its software businesses with Aspen Technology (AZPN) in a roughly $11B deal that values Aspen at around $160 a share, as shareholders would receive $87 and 0.42 share of the combined company for each share they currently own – WSJ https://on.wsj.com/3FxyVx7 · Cleveland-Cliffs ($CLF) agrees to acquire Ferrous Processing and Trading, one of the largest processors and distributors of prime ferrous scrap in the U.S., in a deal with an enterprise value of ~$775M. · Tutor Perini’s ($TPC) joint-venture signed a contract valued at ~$178 million by the U.S. Department of the Interior, Bureau of Reclamation, for the Friant-Kern Canal Middle Reach Capacity Correction Phase I project in central California, southeast of Visalia. Financials · Prudential ($PRU) mentioned positively in Barron’s saying for many years, Prudential Financial’s stock had a nice yield, but it didn’t offer much capital appreciation. The pandemic didn’t help, as the shares lost about 12% last year, dividends included, versus an 18% return for the S&P 500 index. But the market has changed its view, partly owing to an uptick in rates. On top of that, Prudential, whose businesses include life insurance, variable annuities, and asset management, is getting some credit for more-consistent earnings in recent years. Healthcare · Supernus Pharmaceuticals, Inc. ($SUPN) to acquire Adamas Pharmaceuticals, Inc. (ADMS) through a tender offer for $8.10 per share in cash (or an aggregate of approximately $400 million), payable at closing plus two non-tradable contingent value rights (CVR) collectively worth up to $1.00 per share in cash (or an aggregate of approximately $50 million), for a total consideration of $9.10 per share in cash (or an aggregate of approximately $450 million). · AstraZeneca ($AZN) Phase 3 trial met its primary end point; trial showed a reduced risk of death & severe C-19 by 67% in a trial where 90% of participants were from high-risk categories; only long acting antibody combination that can both prevent & treat C-19 · Merck ($MRK) submitted an Emergency Use Authorization (EUA) application to the U.S. FDA for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 who are at risk for progressing to severe COVID-19 and/or hospitalization · Regenxbio ($RGNX) announces initial data from the ongoing Phase II ALTITUDE trial of RGX-314 for the treatment of diabetic retinopathy (DR) without center-involved diabetic macular edema (CI-DME) using in-office suprachoroidal delivery. · BeiGene ($BGNE) announced that BRUKINSA has been approved in Australia for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy Technology, Media & Telecom · Apple ($AAPL) asked a federal appeals court on Friday to throw out a legal decision that would require the tech giant to tweak its strict App Store rules and force it to allow app developers to inform customers of ways to pay for subscriptions and services outside the App Store – NYT · Gray Television ($GTN) a positive mention in Barron’s saying at about $23.50 a share, it has a price/earnings ratio of five based on 2022 estimates. It looks like an inexpensive way to bet on broadcast as Gray’s strength in local news helps it make a killing in political ads · Toshiba Corp ($6502.T) said it would announce the results of a strategic review of its business along with its quarterly earnings results and a new mid-term business plan on Nov. 12. A spokesperson said the results of Toshiba’s strategic review would be part of the new business plan. The company had previously said the review would be announced this month. · U.S.-listed Chinese tech stocks Alibaba ($BABA), JD.com ($JD) and Baidu ($BIDU) among market leaders early; BABA shares up over 5% after Reuters noted the Daily Journal Corp, chaired by Berkshire Hathaway Vice Chairman Charlie Munger, boosted its holdings in BABA by 83% during Q3, according to public disclosures. Also helping sentiment in China listed stocks, China’s antitrust regulator also fines delivery giant Meituan 3.4 bln yuan ($527.4 mln), a smaller than expected figure, for abusing its dominant market position · Comcast ($CMCSA) downgraded to Market Perform from Outperform at Raymond James
117 Replies 13 👍 14 🔥
@DarkPoolAlgo #Dark Pool Charts
recentlyDAY TRADES!! 1. $MRNA: (Gapping Up) Long above 458 for a run to 463-465. Otherwise, short it below 455 for a nice sell off to 450-451. 2. $CRWD: (downgraded by goldman) Downgraded to 305 so not really crazy. The goal here is looking at daily to see where it can go. Long above 259.50 for a quick pop to 261-262. Otherwise, short it below 257.50 for a sell off to 249-251. 3. $NVAX: (gapping up) Long above 250 for a nice run to 255-257. Otherwise short it below 246 for a sell off to 240-242. 4. $ATER: (gapping up) Long above 15 for a run to 15.50-16.00. If it does get over 15 look at daily for levels of resistance. Otherwise, short it below 13 for a quick sell off to 11.50-12 before a curl back. 5. $ASAN: (upgraded by analyst) Long above 103.50 for a quick run to 107-109. Otherwise, short it below 100 for a quick 2-3 point drop. 6. $VALN: (covid vaccine terminated UK) Long above $33 for a nice run to 36-37 (maybe even gap fill). Otherwise, short it below 28 for a quick sell off to 24-25. 7. $RGNX: (partner with ABBV) Gapping up 22%. Long above 41.50 for a quick run to 44-45. Otherwise, short it below 39 for a sell off to 35-37. 8. $NVDA: (gapping up) Long above 227.50 for a quick 1-2 point run before it starts topping off. otherwise, short it below 226 for a quick 1-2 point sell off. (Ideally want 230.50 all time high breakout for a nice push to 232) TOTALLY BORROWED THIS
51 Replies 9 👍 13 🔥
@DarkPoolAlgo #Dark Pool Charts
recentlyMonday, September 13, 2021 Futures Up/Down % Last Dow 233.00 0.68% 34,724 S&P 500 27.25 0.61% 4,476 Nasdaq 80.50 0.52% 15,514 Stock futures are looking sharply higher, with the S&P trying to snap its longest losing streak since February (5-days currently) ahead of key economic data this week (CPI and retail sales). Stocks are recovering despite a handful of negative headlines this weekend including a WSJ article that House Dems are considering a 26.5% corporate tax rate from 21.5% with a 3% surtax on individual incomes over $3m, & increasing higher rate capital gains tax to 28.8% from 23.8%. Also this weekend, Sen. Joe Manchin said this weekend he would not vote for the $3.5 trillion budget bill, adding that there’s “no way” to meet the September 27 deadline. In Asian markets, The Nikkei Index gained 65 points to 30,447, the Shanghai Index rose 12 points to 3,715 and the Hang Seng Index dropped -392 points (1.5%) to settle at 25,813. In Europe, the German DAX is surging over 175 points (1.1%) to 15,785, while the FTSE 100 is up over 50 points to 7,075. Stocks slipped all last week as the S&P fell 1.7%, the Dow lost 2.15%, the Nasdaq shed 1.61% as the S&P 500 extended its losing streak to 5-days, the longest since the middle of February. The S&P 500 has rallied over 38% without a 5%+ pullback over the last 309 calendar days. With the European Central Bank offering only a partial tapering of its bond purchases last week, while boosting growth forecasts, investors are now looking at an autumn glide path for stocks based on a similar move by the Federal Reserve later this month. Markets will closely watch the CPI inflation reading after another rise in producer prices (PPI) late last week. Market Closing Prices Yesterday The S&P 500 Index dropped -34.70 points, or 0.77%, to 4,458.58 The Dow Jones Industrial Average fell -271.66 points, or 0.78%, to 34,607.72 The Nasdaq Composite dropped -132.76 points, or 0.87%, to 15,115.49 The Russell 2000 Index declined -21.58 points, or 0.96% to 2,227.55 Events Calendar for Today 2:00 PM ET Federal Budget for August Earnings Calendar: Earnings Before the Open: NSSC, SEAC Earnings After the Close: AVO, CSBR, EPM, ICMB, MTRX, ORCL, RFIL, VOLT Other Key Events: Barclay’s Financial Services Conference (virtual) 2021, 9/13-9/15 BMO Capital 2021 Real Estate Conference (virtual), 9/13-9/14 Citigroup 2021 Global Technology Conference (virtual), 9/13-9/15 Cowen 2nd Annual Health, Wellness & Beauty Summit (virtual), 9/13-9/14 Credit Suisse 34th Annual Basic Materials Conference (virtual), 9/13-9/14 Deutsche Bank 11th Annual Aircraft, Finance & Leasing Conference, 9/13-9/14, in NY JPMorgan Gaming, Lodging, Restaurant & Leisure Management Forum, 9/13-9/14 Piper Global Technology Conference (virtual), 9/13-9/14 Piper 2021 D.C. Bank Field Trip, 9/13-9/15 Wells Fargo 10th Annual Lease REIT Forum (virtual), 9/13 Macro Up/Down Last Nymex 0.96 70.68 Brent 0.86 73.78 Gold +0.90 1,788.50 EUR/USD -0.0033 1.1781 JPY/USD 0.18 110.12 10-Year Note -0.005 1.336% World News House Democrats expect to propose raising the corporate tax rate to 26.5% from 21% and imposing a 3-percentage-point surtax on individual income above $5 million, according to two House Democratic aides familiar with the plans, the WSJ reported. The tax increases would be part of the House Ways and Means Committee’s plans to pay for the party’s priorities in a fast-moving budget bill. Those items include an expanded child tax credit, a national paid-leave program and renewable-energy tax breaks. Joe Manchin said this weekend he would not vote for the $3.5 trillion budget bill, adding that there’s “no way” to meet the September 27 deadline set by House Speaker Nancy Pelosi. Manchin’s comments come as lawmakers work to approve the measure which would invest in climate policy and expand social programs North Korea carried out successful tests of a new long-range cruise missile over the weekend, state media said on Monday Sector News Breakdown Consumer Homebuilders R. Horton ($DHI) and Meritage $(MTH) still look like relative bargains according to Barron’s saying when it comes to builders, book value may no longer be the only metric to look at. DHI, MDC and MTH look historically cheap based on current price/earnings, noting Wall Street analysts see double-digit gains ahead Boston Beer ($SAM) shares tumbled this week after warning of decelerating had seltzer category, with Barron’s saying with the stock now worth less than half what it was at its peak, it might be time to take a look at shares. The stock now looks to have support near $500, around its June 2020 lows. If that level holds, buying the stock in the low $500s could turn out to be a smart bet Toyota Motor Corp ($TM) and Honda Motor Co ($HMC) on Saturday sharply criticized a proposal by Democrats in the U.S. House of Representatives to give union-made electric vehicles in the United States an additional $4,500 tax incentive. Leslie’s ($LESL) files to sell 13M shares of common stock for holders MGM Resorts ($MGM) upgraded to Outperform from Market Perform at Bernstein Nike ($NKE) downgraded to Neutral from Buy at BTIG Stanley Black & Decker ($SWK) announced that it has entered into a definitive agreement to acquire Excel Industries for $375 million in cash. Energy, Industrials and Materials Virgin Galactic ($SPCE) said this weekend that the flight window for Unity 23 will be pushed back to mid-October at the earliest after a third-party supplier flagged a potential manufacturing defect in a component of the flight control actuation system. It is not yet known if the defect is present in any of Virgin’s vehicles or any repair work will be needed. Kansas City Southern (KSU) said on Sunday it planned to accept Canadian Pacific Railway’s ($CP) $27.2 billion cash-and-stock acquisition offer as superior to its $29.6 billion deal to sell itself to Canadian National Railway ($CNI), according to Reuters. Canadian National now has until the end of Friday to submit a better offer or lose its deal with Kansas City Southern. Rocket Lab USA ($RKLB) mentioned cautiously in Barron’s saying after a strong run for shares, it’s time to think about taking some profits. Recent positive news has sent shares skyrocketing, leaving even the most bullish investors wondering that to do next Atlas Air Worldwide ($AAWW) subsidiary, Atlas Air completes five-year joint collective bargaining agreement for its Atlas Air and Southern Air pilots. Trane Technologies ($TT) signed an agreement to acquire Farrar Scientific, a leader in ultra-low temperature control for biopharmaceutical and other life science applications for $250M US Well Services ($USWS) said it received written notice from the Nasdaq on Sept 7 indicating it had failed to comply with the minimum closing bid price requirement rule and will therefore be de-listed Louisiana declared a state of emergency ahead of Tropical Storm Nicholas Financials Beijing wants to break up Alipay, the hugely popular payments app owned by Jack Ma’s Ant Group, and create a separate app for the company’s highly profitable loans business, the Financial Times reported on Sunday. The plan will also see Ant turn over the user data that underpins its lending decisions to a new credit scoring joint-venture, which will be partly state-owned, the newspaper reported TransUnion ($TRU) said it has agreed to buy information-services company Neustar Inc. for $3.1 billion in cash, a move that sets the consumer-credit reporting giant to diversify beyond its core business and put data to new uses. The Chicago-based company Monday said it is buying Neustar from a private investment group led by Golden Gate Capital https://on.mktw.net/3tBRVou SVB Financial Group ($SIVB) mentioned positively in Barron’s saying the bank stands out in the stodgy world of banking because of its unusual role as a leading lender to innovative tech start-ups. While some banks have struggled to grow their loan book over the past year, SVB had 8% QoQ growth in loan balances, reflecting strong activity in the tech and healthcare sectors KeyCorp (KEY) sold its $3.2B indirect retail auto loan portfolio to a vehicle managed by a subsidiary of Waterfall Asset Management, and will use capital generated by the sale to buy back some of its stock. Healthcare Dynavax ($DVAX) shares slide -16%; as the British government ends a COVID-19 vaccine supply deal with French vaccine maker Valneva SE, alleging a breach of obligations that Valneva denies. Valneva is developing its COVID-19 vaccine, VLA2001, combined with DVAX’s adjuvant or vaccine booster, CpG 1018 AbbVie ($ABBV) and REGENXBIO ($RGNX) form a strategic partnership combining eye care and gene therapy expertise- Companies will develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases- REGENXBIO to receive $370 million upfront payment Leap Therapeutics ($LPTX) said it will be presenting initial data from the first-line cohort of the DisTinGuish study, a Phase 2a clinical trial evaluating Leap’s anti-Dickkopf-1, or DKK1, antibody, DKN-01, in combination with tislelizumab, BeiGene’s anti-PD-1 antibody, and chemotherapy, in patients with gastric or gastroesophageal junction cancer, at the European Society for Medical Oncology, or ESMO, Congress, being held virtually on September 16-21 MiMedx Group (MDXG) shares fall -19% as reports Top-line Data from Two Late-Stage Musculoskeletal Trials. Top-line results from an interim analysis of the Phase 2B trial for KOA did not meet primary endpoints. Top-line results from Phase 3 Plantar Fasciitis trial did not meet its primary endpoints. Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official. mostly uses the vaccine made by Pfizer ($PFE) and BioNTech ($BNTX), but also uses Moderna ($MRNA) Hepion Pharmaceuticals ($HEPH) schedules conference call to review data from phase 2a ‘AMBITION’ clinical trial of CRV431 in NASH; it expects to release additional data from its Phase 2a ‘AMBITION’ NASH clinical trial before the market opens on Monday, September 13, 2021. Technology, Media & Telecom Cisco ($CSCO mentioned in Barron’s noting the company is meeting with analysts on Wednesday for the first time in four year and the session could make or break the shares. The networking giant’s sales suffered last year as companies cut information technology spending early in the pandemic. But the trend has reversed in Cisco’s favor ViacomCBS Inc ($VIAC) is revamping the operations of its Paramount Pictures movie and television production unit under a broader management shake-up, the Wall Street Journal reported on Sunday, citing people familiar with the matter. The realignment will see Paramount Television expected to focus primarily on making content for its sister cable and streaming networks Canon ($CAJ) announced that it has reached an agreement with Redlen Technologies to conclude a share transfer agreement, making Redlen a wholly owned subsidiary of Canon
128 Replies 15 👍 13 🔥
Key Metrics
Market Cap
835.42 M
Beta
1.22
Avg. Volume
440.51 K
Shares Outstanding
43.47 M
Yield
0%
Public Float
0
Next Earnings Date
2023-08-03
Next Dividend Date
Company Information
regenxbio is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (aav) gene therapy. regenxbio's nav® technology platform, a proprietary aav gene delivery platform, consists of exclusive rights to more than 100 novel aav vectors, including aav7, aav8, aav9 and aavrh10. regenxbio's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on regenxbio's nav technology platform. regenxbio seeks to accomplish this mission through a combination of internal development efforts and third‐party nav technology platform licensees.
CEO: Kenneth Mills
Website: regenxbio.com
HQ: 9600 Blackwell Rd Ste 210 Rockville, 20850-3655 Maryland
Related News